Elicio Therapeutics Inc.

-0.18 (-2.25%)
4:49:15 PM EDT: $7.70 -0.11 (-1.41%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Elicio Therapeutics Inc. Stock, NASDAQ:ELTX

451 D Street, 5th floor, Boston, Massachusetts 02210
United States of America
Phone: +1.857.209.0050
Number of Employees: 12


Elicio Therapeutics, Inc. engages in the development of vaccines for infectious disease and cancer. Its programs focus on a novel lipid nanocapsule platform technology for delivering vaccines in a form mimicking the structure of pathogens to elicit potent immunity in prophylactic and therapeutic settings. The company was founded by Satish Jindal and Darrell Irvine on August 10, 2011 and is headquartered in Boston, MA.